Market Overview

D.A. Davidson Sees Modest Q4 Profit Near Expectations For McDermott International


In a report published Tuesday, D.A. Davidson analyst John B. Rogers reiterated a Buy rating and $2.50 price target on McDermott International, Inc. (NYSE: MDR).

In the report, D.A. Davidson noted, "Reported EPS of $0.03 for the fourth quarter. This was an improvement from a loss of $1.37 last year and was near our estimate of $0.01 per share (consensus called for a loss of $0.06). These results brought the full-year loss to $0.32 per share compared to a loss of $2.19 in 2013."

McDermott International closed on Monday at $2.61.

Latest Ratings for MDR

Sep 2019MaintainsNeutral
Sep 2019MaintainsNeutral
Jul 2019MaintainsNeutral

View More Analyst Ratings for MDR
View the Latest Analyst Ratings

Posted-In: D.A. Davidson John B. RogersAnalyst Color Reiteration Analyst Ratings


Related Articles (MDR)

View Comments and Join the Discussion!

Latest Ratings

PNRJefferiesInitiates Coverage On
IPHIBank of AmericaMaintains80.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Benzinga's Top Initiations

Adamis Pharmaceuticals Announces Positive Pharmacokinetic Study Results For Its Dry Powder Inhaler Product